Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.

[1]  Xing-xiang Wang,et al.  Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. , 2004, Clinical science.

[2]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[3]  M. Hayashi,et al.  Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[4]  R. Vile,et al.  Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells. , 2004, American journal of physiology. Heart and circulatory physiology.

[5]  Eun-Seok Jeon,et al.  Decreased Number and Impaired Angiogenic Function of Endothelial Progenitor Cells in Patients With Chronic Renal Failure , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[6]  L. Shaw,et al.  Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.

[7]  P. Lambiase,et al.  Circulating Humoral Factors and Endothelial Progenitor Cells in Patients With Differing Coronary Collateral Support , 2004, Circulation.

[8]  Stefanie Dimmeler,et al.  Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. , 2004, Circulation.

[9]  Stefanie Dimmeler,et al.  Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. , 2004, Circulation.

[10]  F. Emmrich,et al.  Increase of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease After Exercise-Induced Ischemia , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[11]  W. Schaper,et al.  A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. , 2004, Circulation research.

[12]  H. Miller,et al.  Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. , 2004, European heart journal.

[13]  B. Lévy,et al.  Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. , 2004, The American journal of pathology.

[14]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  D. Heistad,et al.  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004 , 2004 .

[16]  Frank J T Staal,et al.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.

[17]  R. Vile,et al.  Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood , 2003, Circulation research.

[18]  C. Heeschen,et al.  Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. , 2003, Blood.

[19]  M. Hristov,et al.  Endothelial progenitor cells: isolation and characterization. , 2003, Trends in cardiovascular medicine.

[20]  A. Avogaro,et al.  Visceral obesity is characterized by impaired nitric oxide-independent vasodilation. , 2003, European heart journal.

[21]  C. Cobelli,et al.  L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. , 2003, Diabetes.

[22]  Arshed A. Quyyumi,et al.  Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk , 2003 .

[23]  S. Rafii,et al.  VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. , 2003, Blood.

[24]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[25]  R. Lederman,et al.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomized trial☆ , 2002 .

[26]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[27]  R. Lederman,et al.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial , 2002, The Lancet.

[28]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[29]  T. Murohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.

[30]  J. Waltenberger.  Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. , 2001, Cardiovascular research.

[31]  T. Münzel,et al.  Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.

[32]  B. Christy,et al.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.

[33]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[35]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[36]  A. Abacı,et al.  Effect of diabetes mellitus on formation of coronary collateral vessels. , 1999, Circulation.

[37]  M. McDermott.  Ankle brachial index as a predictor of outcomes in peripheral arterial disease. , 1999, The Journal of laboratory and clinical medicine.

[38]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[39]  W. Waldhäusl,et al.  High-Glucose–Triggered Apoptosis in Cultured Endothelial Cells , 1995, Diabetes.

[40]  S. Oparil,et al.  Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats. , 1994, Hypertension.